| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| GLOBUS MEDICAL INC | Director | Class A Common Stock | 24K | $1.37M | $56.98 | Sep 1, 2023 | Direct |
| Hyperfine, Inc. | Director | Stock Options (right to buy) | 79.2K | Jun 12, 2024 | Direct | ||
| GLOBUS MEDICAL INC | Director | Stock Option (Right to Buy Class A Common Stock) | 15K | Jan 26, 2024 | Direct | ||
| NUVASIVE INC | Director | Restricted Stock Unit | 0 | Sep 1, 2023 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
|---|---|---|---|---|---|---|---|
| HYPR | Hyperfine, Inc. | Jun 12, 2024 | 1 | $0 | 4 | Jun 12, 2024 | Director |
| GMED | GLOBUS MEDICAL INC | Jan 26, 2024 | 1 | $0 | 4 | Jan 30, 2024 | Director |
| GMED | GLOBUS MEDICAL INC | Sep 1, 2023 | 2 | $0 | 4 | Sep 6, 2023 | Director |
| GMED | GLOBUS MEDICAL INC | Sep 1, 2023 | 0 | $0 | 3 | Sep 6, 2023 | Director |
| NUVA | NUVASIVE INC | Sep 1, 2023 | 10 | $0 | 4 | Sep 5, 2023 | Director |
| HYPR | Hyperfine, Inc. | Jun 9, 2023 | 2 | $0 | 4/A | Jul 3, 2023 | Director |
| NUVA | NUVASIVE INC | Jun 9, 2023 | 1 | $0 | 4 | Jun 12, 2023 | Director |
| HYPR | Hyperfine, Inc. | Jun 9, 2022 | 1 | $0 | 4 | Jun 13, 2022 | Director |
| NUVA | NUVASIVE INC | May 11, 2022 | 1 | $0 | 4 | May 13, 2022 | Director |
| HYPR | Hyperfine, Inc. | Dec 23, 2021 | 1 | $0 | 4/A | Jan 10, 2022 | Director |
| HYPR | Hyperfine, Inc. | Dec 22, 2021 | 0 | $0 | 3 | Dec 23, 2021 | Director |
| NUVA | NUVASIVE INC | May 18, 2021 | 1 | $0 | 4 | May 20, 2021 | Director |